These authors contributed equally to this work.
No association between CCL2 gene polymorphisms and risk of inflammatory demyelinating diseases in a Korean population
Version of Record online: 2 MAY 2014
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Volume 84, Issue 2, pages 223–228, August 2014
How to Cite
Namgoong, S., Bae, J. S., Cheong, H. S., Kim, J.-H., Kim, J. Y., Kim, L. H., Kim, H. J. and Shin, H. D. (2014), No association between CCL2 gene polymorphisms and risk of inflammatory demyelinating diseases in a Korean population. Tissue Antigens, 84: 223–228. doi: 10.1111/tan.12358
- Issue online: 25 JUL 2014
- Version of Record online: 2 MAY 2014
- Manuscript Accepted: 25 MAR 2014
- Manuscript Revised: 10 MAR 2014
- Manuscript Received: 25 OCT 2013
- Korea Government (MEST). Grant Number: NRF-2010-0011206
- Ministry of Education, Science and Technology. Grant Number: 2012-0006690
|tan12358-sup-0001-TableS1.doc||Word document||72K||Table S1. Association of CCL2 SNPs with IDD, NMO, and MS susceptibility under dominant and recessive models.|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.